Skip Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 18, Issue 2

2026 January-2 - 170 articles

Cover Story: Pancreatic ductal adenocarcinoma frequently spreads to the peritoneal cavity, where systemic chemotherapy has limited effectiveness and outcomes remain poor. This systematic review examines emerging intraperitoneal chemotherapy strategies—including hyperthermic intraperitoneal chemotherapy (HIPEC), normothermic intraperitoneal paclitaxel, and pressurized intraperitoneal aerosol chemotherapy (PIPAC)—across adjuvant, cytoreductive, and palliative settings. By synthesizing clinical outcomes, feasibility, and biological rationale, we highlight how regional therapies may improve locoregional control, symptom burden, and survival in carefully selected patients. This work provides a comprehensive framework for patient selection, clinical integration, and future trial design in pancreatic cancer with peritoneal involvement. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (170)

  • Article
  • Open Access
339 Views
19 Pages

Fatty Acid Synthase as a Potential Metabolic Vulnerability in Ocular Adnexal Sebaceous Carcinoma

  • Autumn Berlied,
  • Isabella Boyack,
  • Andre Vieira,
  • Maria Gonzalez-Perez,
  • Vikas Kumar and
  • Cornelia Peterson

22 January 2026

Background: MYC dysregulation is frequent in ocular adnexal sebaceous carcinoma (SebCA), an aggressive malignancy without precision therapy. Fatty acid synthase (FASN) expression and lipid metabolism are commonly perturbed in high-MYC-expressing tumo...

  • Review
  • Open Access
271 Views
12 Pages

22 January 2026

An increasing number of young women with hormone receptor-positive (HR+) early breast cancer desire pregnancy after treatment. Prolonged adjuvant endocrine therapy, concerns regarding recurrence risk, and treatment-related fertility decline have hist...

  • Article
  • Open Access
236 Views
14 Pages

Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective Analysis

  • Sabrina Pelliccia,
  • Marta Banchi,
  • Lucrezia De Marchi,
  • Emanuele Cencini,
  • Claudia Seimonte,
  • Alberto Fabbri,
  • Andrea Nunzi,
  • Susanna Destefano,
  • Guido Bocci and
  • Maria Christina Cox

22 January 2026

Background/Objectives: Relapsed or refractory follicular lymphoma (rrFL) remains difficult to treat in elderly or frail patients who cannot tolerate standard-dose immuno-chemotherapy as well as novel therapies. Metronomic chemotherapy (mCHEMO) may of...

  • Article
  • Open Access
174 Views
14 Pages

Nationwide Survival Impact of Bevacizumab Under National Reimbursement for Advanced Cervical Cancer in South Korea

  • Junhwan Kim,
  • Jieun Jang,
  • Krishnansu S. Tewari,
  • Kyung Su Kim,
  • Hyun-Cheol Kang and
  • Sokbom Kang

22 January 2026

Background: The aim of this study was to evaluate the effectiveness of bevacizumab in advanced cervical cancer (CC) patients using nationwide data after its inclusion in South Korea’s National Health Insurance (NHI), considering various clinico...

  • Article
  • Open Access
179 Views
20 Pages

Clinical Behavior of Aggressive Variants of Papillary Thyroid Carcinoma: A Retrospective Case–Control Study

  • Jovan Ilic,
  • Nikola Slijepcevic,
  • Katarina Tausanovic,
  • Bozidar Odalovic,
  • Goran Zoric,
  • Marija Milinkovic,
  • Branislav Rovcanin,
  • Milan Jovanovic,
  • Matija Buzejic and
  • Vladan Zivaljevic
  • + 5 authors

22 January 2026

Background/Objectives: Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. The classic variant (cPTC) is characterized by indolent behavior and excellent prognosis. However, rare subtypes of PTC most often exhibit adverse clini...

  • Article
  • Open Access
186 Views
15 Pages

Prognostic Factors in the Treatment of Advanced Endometrial Cancer Patients: 12-Year Experience of an ESGO Certified Center

  • Dimitrios Zouzoulas,
  • Iliana Sofianou,
  • Efthalia Markopoulou,
  • Tilemachos Karalis,
  • Kimon Chatzistamatiou,
  • Vasilis Theodoulidis,
  • Maria Topalidou,
  • Eleni Timotheadou,
  • Grigoris Grimbizis and
  • Dimitrios Tsolakidis

22 January 2026

(1) Background: Advance-stage endometrial cancer is a rare disease that encompasses a heterogeneous group of patients. Primary surgery is the treatment of choice, while neoadjuvant chemotherapy (NACT) seems to be an alternative option for inoperable...

  • Review
  • Open Access
297 Views
18 Pages

Fitness in CLL

  • Claudia Baratè,
  • Ilaria Scortechini,
  • Sara Ciofini,
  • Paola Picardi,
  • Ilaria Angeletti,
  • Federica Loscocco,
  • Alessandro Sanna,
  • Alessandro Isidori,
  • Elisa Grazioli and
  • Paolo Sportoletti

21 January 2026

The increased complexity of CLL management, driven by the advent of targeted therapies, makes it necessary to redefine the concept of fitness, which until a few years ago was limited to the patient’s ability to undergo chemoimmunotherapy. In th...

  • Article
  • Open Access
256 Views
16 Pages

CT Body Composition Changes Predict Survival in Immunotherapy-Treated Cancer Patients: A Retrospective Cohort Study

  • Shlomit Tamir,
  • Hilla Vardi Behar,
  • Ronen Tal,
  • Ruthy Tal Jasper,
  • Mor Armoni,
  • Hadar Pratt Aloni,
  • Rotem Iris Orad,
  • Hillary Voet,
  • Eli Atar and
  • Gal Markel
  • + 2 authors

21 January 2026

Background: Computed tomography (CT)-derived body composition parameters, including skeletal muscle and fat indices, are prognosticators in oncology. Most studies focus on baseline body-composition parameters; however, changes during treatment may pr...

  • Review
  • Open Access
401 Views
31 Pages

Prospective of Colorectal Cancer Screening, Diagnosis, and Treatment Management Using Bowel Sounds Leveraging Artificial Intelligence

  • Divyanshi Sood,
  • Surbhi Dadwal,
  • Samiksha Jain,
  • Iqra Jabeen Mazhar,
  • Bipasha Goyal,
  • Chris Garapati,
  • Sagar Patel,
  • Zenab Muhammad Riaz,
  • Noor Buzaboon and
  • Shivaram P. Arunachalam
  • + 16 authors

21 January 2026

Background: Colorectal cancer (CRC) is the second leading cause of cancer-related mortality worldwide, accounting for approximately 10% of all cancer cases. Despite the proven effectiveness of conventional screening modalities such as colonoscopy and...

  • Article
  • Open Access
311 Views
14 Pages

21 January 2026

Background/Objectives: Physical activity benefits women with metastatic breast cancer. Past trials are typically well-resourced and supervised, but home-based interventions may be preferable and more accessible. This pilot trial evaluated the feasibi...

  • Commentary
  • Open Access
304 Views
10 Pages

21 January 2026

Quiescin sulfhydryl oxidase 1 (QSOX1) is a disulfide bond-forming enzyme with both disulfide isomerase and oxidoreductase activities. It plays an important role in protein folding, stability, and secretion. Growing evidence demonstrates that QSOX1 is...

  • Article
  • Open Access
253 Views
16 Pages

Percutaneous Microwave Ablation Preserves Renal Function with Similar Long Term Oncologic Outcomes Compared to Surgery for Clinical T1 Renal Cell Carcinoma

  • Daniel F. Roadman,
  • Daniel D. Shapiro,
  • Arighno Das,
  • Leslie W. Nelson,
  • Paz Lotan,
  • Michael C. Risk,
  • Kyle A. Richards,
  • Elizabeth L. Koehne,
  • David F. Jarrard and
  • Edwin Jason Abel
  • + 5 authors

21 January 2026

Background/Objectives: Percutaneous microwave (MW) ablation is a nephron sparing treatment for localized renal cell carcinoma (RCC). We compared perioperative, renal functional, and oncologic outcomes for clinical stage 1 RCC treated with MW ablation...

  • Review
  • Open Access
406 Views
35 Pages

Targeting Monocytes and Their Derivatives in Ovarian Cancer: Opportunities for Innovation in Prognosis and Therapy

  • Dharvind Balan,
  • Nirmala Chandralega Kampan,
  • Mohamad Nasir Shafiee,
  • Magdalena Plebanski and
  • Nor Haslinda Abd Aziz

21 January 2026

Ovarian cancer remains the most lethal gynaecological malignancy primarily due to late-stage diagnosis, high recurrence rate, and limited treatment efficacy. Current diagnostic tools, including imaging and serum markers, lack sufficient sensitivity a...

  • Review
  • Open Access
428 Views
21 Pages

21 January 2026

The creation of a specific culture medium for colorectal organoids in 2011 heralded a new era in human primary cultures by enabling the indefinite expansion of normal and pathological epithelial organoids. The original formula has been used ever sinc...

  • Systematic Review
  • Open Access
804 Views
16 Pages

21 January 2026

Background: Leiomyosarcomas are an aggressive soft-tissue sarcoma that arise from smooth muscle, have a high metastatic potential and account for 10–20% of soft-tissue sarcomas. Despite decades of research, the first-line treatment remains unre...

  • Article
  • Open Access
183 Views
10 Pages

Transition from Transrectal Systematic to Transperineal Lesion-Focused Prostate Biopsy: A Real-World Comparative Analysis

  • Thibaut Long Depaquit,
  • Federica Sordelli,
  • Christopher Agüero,
  • Arthur Peyrottes,
  • Alessandro Uleri,
  • Laurent Daniel,
  • David Chemouni,
  • Cyrille Bastide and
  • Michael Baboudjian

21 January 2026

Background/Objectives: The transperineal (TP) approach has progressively replaced the transrectal (TR) approach for prostate biopsy because of its improved safety profile. However, its impact on the detection of clinically significant prostate cancer...

  • Opinion
  • Open Access
195 Views
8 Pages

Does Cachexia Matter for Glioblastoma Multiforme?

  • Ryan Kelly,
  • Lydia Henderson and
  • Ishan Roy

21 January 2026

Cachexia is a muscle-wasting syndrome that has a 50% overall prevalence across all cancers and is known to affect both survival and quality of life. However, its measurement, classification, and impact in individuals with primary brain tumors is uncl...

  • Review
  • Open Access
500 Views
15 Pages

Molecular Insights into Helicobacter pylori-Induced Gastritis and Gastric Cancer

  • Silvia Salvatori,
  • Irene Marafini,
  • Pasquale De Vico,
  • Antonio Fonsi and
  • Giovanni Monteleone

21 January 2026

Helicobacter pylori (H. pylori) is recognized as one of the most widespread and persistent bacterial infections globally, with a remarkable ability to colonize the human stomach. This pathogen is a major contributor to the development of gastric dise...

  • Article
  • Open Access
320 Views
22 Pages

21 January 2026

Background/Objectives: Liver cancer is among the most frequent poor-prognosis malignancies worldwide, with currently insufficient effective treatment. The two-stage microwave hyperthermia using magnetic nanoparticles is a modern technique designed to...

  • Opinion
  • Open Access
470 Views
13 Pages

21 January 2026

The cell division cycle machinery has been regarded as a promising therapeutic target for several decades. One of the most prominent milestones in the approach to targeting the cancer cell cycle was the development and approval of CDK4/6 inhibitors s...

  • Review
  • Open Access
340 Views
30 Pages

21 January 2026

Intrahepatic cholangiocarcinomas (iCCAs) are histologically subdivided into small duct-type (SD-iCCA) and large duct-type (LD-iCCA). LD-iCCA versus SD-iCCA may differ in the molecular/genetic profiles and oncogenesis, including precursor lesions. Whi...

  • Review
  • Open Access
189 Views
17 Pages

Integrated and Comprehensive Diagnostics: An Emerging Paradigm in Precision Oncology

  • Kakoli Das,
  • Jens Samol,
  • Irfan Sagir Khan,
  • Bernard Ho and
  • Khoon Leong Chuah

21 January 2026

Recent advances in molecular pathology, driven by integrated and comprehensive diagnostic approaches, have significantly advanced precision oncology. By leveraging multiomics technologies, molecular pathology enables the simultaneous assessment of ge...

  • Article
  • Open Access
268 Views
14 Pages

Male Breast Cancer in Serbia: A 33-Year Retrospective Cohort Study of Genetic Predisposition, Clinicopathological Features, and Survival Outcomes

  • Zorka Inić,
  • Milan Žegarac,
  • Ana Krivokuća,
  • Ognjen Živković,
  • Marko Buta,
  • Nikola Vučić,
  • Dobrica Stević,
  • Anđela Milićević,
  • Ivan Marković and
  • Igor Đurišić

21 January 2026

Background/Objectives: Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancers. Given its low incidence, male breast cancer (MBC) remains understudied; this 33-year Serbian cohort was assessed for clinicopathological featu...

  • Review
  • Open Access
421 Views
11 Pages

20 January 2026

Non-small cell lung cancer (NSCLC) represents over 80% of all lung cancer cases and still has a huge mortality worldwide. Targeting epidermal growth-factor receptor (EGFR) alterations with overall response rates of more than 80% has provided a paradi...

  • Article
  • Open Access
250 Views
26 Pages

Understanding the Experiences of Adolescents and Young Adults Diagnosed with Cancer During Higher Education—An Exploratory Interview Study

  • Anke W. Boumans,
  • Margo J. van Hartingsveldt,
  • Angela G. E. M. de Boer,
  • Maaike M. Brus,
  • Floor M. Hoddenbagh-Bosdijk,
  • Milou J. P. Reuvers,
  • Jack D. Morgan,
  • Martijn M. Stuiver and
  • Olga Husson

20 January 2026

Background/Objectives: Adolescents and young adults (AYAs) with cancer often begin their careers later in life and are at risk of negative work-related outcomes. Research into and tailored support programs for AYAs diagnosed during higher education r...

  • Article
  • Open Access
308 Views
16 Pages

Preoperative Cachexia as a Predictor of Postoperative Morbidity and a Target for Home-Based Prehabilitation in Resectable Gastric Cancer

  • Vladimir Konstantinovich Lyadov,
  • Tatiana Sergeevna Boldyreva,
  • Alexander Yuryevich Gorshkov,
  • Elena Vitalievna Zyatenkova,
  • Anna Yurievna Ikonnikova,
  • Mikhail Georgievich Chashchin and
  • Vsevolod Nikolaevich Galkin

20 January 2026

Background: Gastric cancer (GC) is one of the most common malignancies, requires aggressive treatment, as has a high incidence of complications. The high prevalence of cachexia and comorbidity among GC patients has led to the development of the &ldqu...

  • Review
  • Open Access
665 Views
35 Pages

Clinical Image-Based Dosimetry of Actinium-225 in Targeted Alpha Therapy

  • Kamo Ramonaheng,
  • Kaluzi Banda,
  • Milani Qebetu,
  • Pryaska Goorhoo,
  • Khomotso Legodi,
  • Tshegofatso Masogo,
  • Yashna Seebarruth,
  • Sipho Mdanda,
  • Sandile Sibiya and
  • Mike Sathekge
  • + 8 authors

20 January 2026

Actinium-225 (225Ac) has emerged as a pivotal alpha-emitter in modern radiopharmaceutical therapy, offering potent cytotoxicity with the potential for precise tumour targeting. Accurate, patient-specific image-based dosimetry for 225Ac is essential t...

  • Article
  • Open Access
170 Views
14 Pages

Is There a Role for Hepatobiliary Scintigraphy in Thermal Ablation of Hepatocellular Carcinoma?

  • Niek Wijnen,
  • Joep de Bruijne,
  • Rutger C. G. Bruijnen,
  • Emma Ruijs,
  • Hugo W. A. M. de Jong,
  • Marnix G. E. H. Lam and
  • Maarten L. J. Smits

20 January 2026

Purpose: Hepatobiliary scintigraphy (HBS) provides quantitative assessment of (future remnant) liver function, aiding clinical decision-making for surgical resection and radioembolization of hepatocellular carcinoma (HCC). However, its role for therm...

  • Article
  • Open Access
232 Views
16 Pages

Oncological Outcomes and Genomic Features of Gastric-Type Endocervical Adenocarcinoma, the Most Aggressive and Common HPV-Independent Cervical Cancer

  • Ming Du,
  • Zhen Zheng,
  • Peiyao Lu,
  • Weidi Wang,
  • Dongyan Cao,
  • Jiaxin Yang,
  • Ming Wu,
  • Lingya Pan,
  • Xiaowei Xue and
  • Yang Xiang
  • + 2 authors

20 January 2026

Background/Objectives: In order to develop a comprehensive understanding of gastric-type endocervical adenocarcinoma (GEA), an increasingly prevalent HPV-independent cervical cancer, we summarized clinicopathological information and performed prognos...

  • Article
  • Open Access
225 Views
13 Pages

HDR Brachytherapy in the Treatment of Skin Kaposi Sarcoma: A Mono-Institutional Series

  • Bianca Santo,
  • Elisa Ciurlia,
  • Maria Cristina Barba,
  • Elisa Cavalera,
  • Rosa Coppola,
  • Paola De Franco,
  • Sara De Matteis,
  • Giuseppe Di Paola,
  • Angela Leone and
  • Angela Sardaro
  • + 4 authors

20 January 2026

Background: Kaposi sarcoma (KS) is a multifocal, angioproliferative neoplasm strongly associated with human herpesvirus-8 infection. Radiotherapy(RT) is a well established treatment due to the intrinsic radiosensitivity of KS lesions. High-dose-rate...

  • Review
  • Open Access
448 Views
43 Pages

An Overview of the Mechanisms of HPV-Induced Cervical Cancer: The Role of Kinase Targets in Pathogenesis and Drug Resistance

  • Medha Karnik,
  • SubbaRao V. Tulimilli,
  • Preethi G. Anantharaju,
  • Anjali Devi S. Bettadapura,
  • Suma M. Natraj,
  • Habeeb S. Mohideen,
  • Sinisa Dovat,
  • Arati Sharma and
  • SubbaRao V. Madhunapantula

20 January 2026

Despite a thorough understanding of the structure of human papillomavirus (HPV) and its genotypic variations (high-risk and low-risk variants), the mechanisms underlying HPV-induced cervical cancer (CC) pathogenesis and the molecular signatures of dr...

  • Article
  • Open Access
235 Views
12 Pages

Initial Experience with Correlation Object–Based DRR Targeting Using Stereoscopic X-Ray Imaging in Lung SBRT

  • Marlies Boussaer,
  • Cristina Teixeira,
  • Kajetan Berlinger,
  • Selma Ben Mustapha,
  • Anne-Sophie Bom,
  • Sven Van Laere,
  • Mark De Ridder and
  • Thierry Gevaert

20 January 2026

Background/Objectives: Despite significant advances in imaging technology, real-time intra-fraction monitoring of moving targets remains a challenge in markerless radiotherapy. This retrospective study investigates the use of ExacTrac Dynamic by Brai...

  • Article
  • Open Access
174 Views
12 Pages

Synchrotron Radiation–Excited X-Ray Fluorescence (SR-XRF) Imaging for Human Hepatocellular Carcinoma Specimens

  • Masakatsu Tsurusaki,
  • Keitaro Sofue,
  • Kazuhiro Kitajima,
  • Takamichi Murakami and
  • Noboru Tanigawa

20 January 2026

Background/Objectives: Trace metals, including copper (Cu) and zinc, are associated with the development and prognosis of hepatocellular carcinoma (HCC). However, their interference with magnetic resonance imaging (MRI) limits their use as potential...

  • Review
  • Open Access
228 Views
14 Pages

Non-Transplantable Recurrence After Initial Liver Resection of Hepatocellular Carcinoma: A Narrative Review

  • Dima Malkawi,
  • Ioannis A. Ziogas,
  • Ana L. Gleisner,
  • Richard D. Schulick and
  • Dimitrios P. Moris

20 January 2026

Background/Objectives: Hepatocellular carcinoma (HCC) constitutes a leading cause of mortality worldwide. Liver transplantation (LT) and liver resection (LR) represent the main curative-intent treatment modalities for early-stage HCC. LT can offer th...

  • Systematic Review
  • Open Access
267 Views
14 Pages

The Efficacy of Electronic Health Record-Based Artificial Intelligence Models for Early Detection of Pancreatic Cancer: A Systematic Review and Meta-Analysis

  • George G. Makiev,
  • Igor V. Samoylenko,
  • Valeria V. Nazarova,
  • Zahra R. Magomedova,
  • Alexey A. Tryakin and
  • Tigran G. Gevorkyan

20 January 2026

Background: The persistently low 5-year survival rate for pancreatic cancer (PC) underscores the critical need for early detection. However, population-wide screening remains impractical. Artificial Intelligence (AI) models using electronic health re...

  • Article
  • Open Access
225 Views
14 Pages

20 January 2026

Background: The combination of hepatic arterial infusion chemotherapy (HAIC) with immune checkpoint inhibitors (ICIs) and anti-angiogenic agents represents a potential therapeutic strategy for advanced hepatocellular carcinoma (HCC). This study aimed...

  • Article
  • Open Access
196 Views
10 Pages

Impact of Hypoalbuminemia on Morbidity and Mortality After Radical Cystectomy

  • Sri Saran Manivasagam,
  • Jay D. Raman and
  • Matthew G. Kaag

20 January 2026

Objective: To evaluate the role of serum albumin in predicting surgical outcomes after radical cystectomy. Methods: Retrospective cohort analysis of adults who underwent radical cystectomy from 2019 to 2022 within the ACS NSQIP dataset. Patients were...

  • Article
  • Open Access
241 Views
16 Pages

Genomic and Molecular Associations with Preoperative Immune Checkpoint Inhibition in Patients with Stage III Clear Cell Renal Cell Carcinoma

  • Wesley H. Chou,
  • Lucy Lawrence,
  • Emma Neham,
  • Shreeram Akilesh,
  • Amy E. Moran,
  • Christopher L. Corless,
  • Lisa Langmesser,
  • Beyza Cengiz,
  • Kazumi Eckenstein and
  • George V. Thomas
  • + 5 authors

20 January 2026

Background and Objective: Patients with stage III clear cell renal cell carcinoma (ccRCC) have a high risk for disease recurrence post-nephrectomy. To mitigate overtreatment, there is a pressing need to determine who benefits from immune checkpoint i...

  • Article
  • Open Access
193 Views
13 Pages

Unveiling the Female Factor: Gender-Based Differences in Outcomes and Survival Following Radical Cystectomy for Bladder Cancer

  • Federico Ceria,
  • Gad Muhammad,
  • Francesco Del Giudice,
  • Youssef Ibrahim,
  • Ramesh Thurairaja,
  • Rajesh Nair,
  • Elsie Mensah,
  • Muhammad Shamim Khan and
  • Yasmin Abu Ghanem

20 January 2026

Background: Female patients undergoing radical cystectomy (RC) for bladder cancer have historically presented with more advanced disease and poorer survival outcomes than males. These disparities have been attributed to biological differences, delaye...

  • Article
  • Open Access
353 Views
20 Pages

An Inducible BRCA1 Expression System with In Vivo Applicability Uncovers Activity of the Combination of ATR and PARP Inhibitors to Overcome Therapy Resistance

  • Elsa Irving,
  • Alaide Morcavallo,
  • Jekaterina Vohhodina-Tretjakova,
  • Paul W. G. Wijnhoven,
  • Anna L. Beckett,
  • Michael P. Jacques,
  • Rachel S. Evans,
  • Jennifer I. Moss,
  • Anna D. Staniszewska and
  • Josep V. Forment

20 January 2026

Background: Poly(ADP-ribose) polymerase inhibitors (PARPi) have transformed cancer therapy for patients harbouring homologous recombination repair (HRR) deficiencies, notably BRCA1/2 mutations. However, resistance to PARPi remains a clinical challeng...

  • Article
  • Open Access
226 Views
11 Pages

The Future Is Bright for Women in Urologic Oncology: Trends over Two Decades

  • Gabrielle R. Yankelevich,
  • Reid DeMass,
  • Luis G. Medina,
  • Tara Sweeney,
  • Robert L. Grubb,
  • Stephen J. Savage and
  • Matvey Tsivian

20 January 2026

Background/Objectives: The role of female surgeons in urology has been steadily increasing. We performed a contemporary review of American Board of Urology (ABU) case logs focused on oncologic procedures and evaluated the role of female surgeons over...

  • Article
  • Open Access
276 Views
25 Pages

Evaluating the Therapeutic Potential of MRT68921 and Afatinib in Three-Dimensional Models of Epithelial Ovarian Cancer

  • Tiffany P. A. Johnston,
  • Jack D. Webb,
  • Matthew J. Borrelli,
  • Emily J. Tomas,
  • Áine C. Pucchio,
  • Yudith Ramos Valdés and
  • Trevor G. Shepherd

19 January 2026

Background/Objectives: Epithelial ovarian cancer (EOC) is often diagnosed at advanced stages, with metastasis driven by spheroid dissemination within the peritoneal cavity. We previously demonstrated that autophagy supports spheroid cell survival and...

  • Review
  • Open Access
244 Views
13 Pages

Predicting the Unpredictable: AI-Driven Prognosis in Pancreatic Neuroendocrine Neoplasms

  • Elettra Merola,
  • Emanuela Pirino,
  • Stefano Marcucci,
  • Franca Chierichetti,
  • Andrea Michielan,
  • Laura Bernardoni,
  • Armando Gabbrielli,
  • Maria Pina Dore,
  • Giuseppe Fanciulli and
  • Alberto Brolese

19 January 2026

The clinical management of Pancreatic Neuroendocrine Neoplasms (Pan-NENs) is complicated by the disease’s intrinsic variability, which creates significant hurdles for accurate risk profiling and the standardization of treatment protocols. Recen...

  • Article
  • Open Access
276 Views
15 Pages

Experience of a Referral Center with Desmoid Tumors, Part 2: A Retrospective Analysis of 109 Cases

  • Alvarez Alvarez Rosa,
  • Agra Pujol Carolina,
  • Arregui Valles Marta,
  • Alijo Francisco,
  • Fernández Gonzalo Adriana,
  • Gutiérrez Natalia,
  • Lozano Lominchar Pablo,
  • Mata Fernández Cristina,
  • Mediavilla Santos Lydia and
  • Gutiérrez-Ortiz de la Tabla Ana
  • + 4 authors

19 January 2026

Background: Desmoid tumors (DTs) are rare, locally aggressive fibroblastic neoplasms with highly heterogeneous clinical behavior. The present work constitutes the second part of a two-part project, following our previously published multidisciplinary...

  • Review
  • Open Access
282 Views
42 Pages

Quantitative Imaging Advances in HPV-Positive Oropharyngeal Carcinoma

  • Dermot Farrell,
  • Houda Bahig,
  • Richard Khor,
  • Luiz P. Kowalski,
  • Remco de Bree,
  • Avraham Eisbruch,
  • Heleen Bollen,
  • Fernando Lopez,
  • M. P. Sreeram and
  • Sweet Ping Ng
  • + 7 authors

19 January 2026

HPV-positive OPSCC shows a favourable prognosis, prompting evaluation of de-escalated and adaptive strategies. Quantitative imaging may provide scalable biomarkers to individualise care. Quantitative imaging can support baseline risk stratification,...

  • Review
  • Open Access
314 Views
20 Pages

Clinical Trials Update in Resectable Esophageal Cancer

  • Aaron J. Dinerman and
  • Shamus R. Carr

19 January 2026

Management of resectable esophageal cancer has evolved into a multidisciplinary paradigm centered on multimodality therapy. Historically, induction chemoradiotherapy followed by surgery, as established by the CROSS trial, became the standard of care...

  • Review
  • Open Access
200 Views
16 Pages

Emergent Role of Intra-Tumor Radioactive Implantation in Pancreatic Cancer

  • Pathipat Durongpongkasem,
  • Amanda H. Lim and
  • Nam Q. Nguyen

19 January 2026

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, with limited treatment options for patients with locally advanced or metastatic disease. Endoscopic ultrasound (EUS)-guided intra-tumoral radioactive implantation ha...

  • Article
  • Open Access
178 Views
14 Pages

Prognostic Value of Phosphatidylinositol-3 Kinase p110 α Protein Expression in Patients with Stage I–III Invasive Breast Cancer

  • Zhiqiang Zong,
  • Xuan Zhou,
  • Jian Shen,
  • Min Yan,
  • Xi Xia,
  • Jingjing Li,
  • Xian Wang and
  • Fanfan Li

19 January 2026

Background: The prognostic value of phosphatidylinositol-3-kinase p110α, a key catalytic subunit in the PI3K/AKT pathway, in breast cancer remains controversial. This study evaluated its prognostic significance in stage I–III invasive bre...

  • Article
  • Open Access
215 Views
10 Pages

Predictors of Peritoneal Surface Recurrence and Quantitative Association with Time to Relapse After Complete CRS/HIPEC for Colorectal Peritoneal Metastasis

  • Corey A. Hounschell,
  • Aubrey C. Swilling,
  • Sahaam Mirza,
  • Katelyn Sanner-Dixon,
  • Jill Haley,
  • Luke V. Selby,
  • Shahid Umar and
  • Mazin Al-Kasspooles

19 January 2026

Background/Objectives: Peritoneal surface metastases (PSMs) from colorectal cancer have high rates of peritoneal recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Prior studies dichotomize peritoneal...

of 4

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694